On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...